Management of Patients with Ventricular Tachyarrhythmias: Does an Optimal Therapy Exist?
- 1 March 1994
- journal article
- review article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 17 (3), 559-570
- https://doi.org/10.1111/j.1540-8159.1994.tb01426.x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effects of chronic amiodarone therapy on defibrillation thresholdThe American Journal of Cardiology, 1992
- Sotalol in patients with life-threatening ventricular tachyarrhythmiasCardiovascular Drugs and Therapy, 1990
- Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarctsThe American Journal of Cardiology, 1989
- Clinical experience with sotalol in patients with drug-refractory ventricular ArrhythmiasJournal of the American College of Cardiology, 1989
- Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugsThe American Journal of Cardiology, 1988
- Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery diseaseThe American Journal of Cardiology, 1988
- Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillatorThe American Journal of Cardiology, 1987
- Concentration-dependent pharmacologic properties of sotalolThe American Journal of Cardiology, 1986
- Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.Circulation, 1984
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsNew England Journal of Medicine, 1980